Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-54,173
Closed -$1.23M 724
2024
Q1
$1.23M Sell
54,173
-18,411
-25% -$431K 0.12% 287
2023
Q4
$1.8M Sell
72,584
-136,302
-65% -$2.66M 0.2% 169
2023
Q3
$3.57M Buy
208,886
+56,713
+37% +$944K 0.45% 48
2023
Q2
$2.52M Sell
152,173
-77,861
-34% -$1.25M 0.35% 76
2023
Q1
$4.04M Buy
230,034
+52,594
+30% +$795K 0.55% 17
2022
Q4
$2.26M Sell
177,440
-16,264
-8% -$201K 0.37% 69
2022
Q3
$2.44M Sell
193,704
-44,089
-19% -$773K 0.37% 46
2022
Q2
$4.33M Buy
237,793
+133,502
+128% +$2.5M 0.38% 34
2022
Q1
$2.25M Sell
104,291
-37,472
-26% -$1.26M 0.19% 145
2021
Q4
$6.11M Buy
+141,763
New +$6.99M 0.47% 22

Other funds holding PATH

PDT Partners's PATH Position: Q2 2024 in Review

PDT Partners sold out of UiPath (PATH) in Q2 2024, closing a stake of 54,173 shares — an estimated $1.23M sold.

PDT Partners first reported a position in PATH in Q4 2021 and held it in 10 quarters. The position peaked at $6.11M in Q4 2021. 478 funds tracked by Wall St. Rank hold PATH as of Q2 2024.

  • PDT Partners reported no remaining UiPath position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 54,173 UiPath shares in Q2 2024, an estimated $1.23M.
  • PDT Partners first reported a position in UiPath in Q4 2021 and held it in 10 quarters.
  • PDT Partners's UiPath position peaked at $6.11M in Q4 2021.
  • 478 funds tracked by Wall St. Rank held UiPath as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.